Lantheus Holdings exceeded Q2 earnings and revenue forecasts, driven by stronger-than-expected demand for its medical imaging products.
Lantheus Holdings reported Q2 non-GAAP earnings per share of $1.46, beating estimates by $0.23, as revenue reached $377.3M, $22.88M above expectations.
The company’s results surpassed the consensus forecast, reflecting robust performance in its core imaging segment. Revenue grew compared to the prior-year period, supported by higher sales volumes and pricing.
Shares showed limited movement in after-hours trading as investors digested the earnings beat.